Association of Red Cell Index and Adverse Hospitalization Outcomes in Chronic Obstructive Pulmonary Disease Patients with Acute Exacerbation: A Retrospective Cohort Study
Fu-zhen Yuan,Wei Shui,Yan-li Xing,Yuan-yuan Niu,Xin Zhang,Chang-ran Zhang
DOI: https://doi.org/10.2147/COPD.S373114
2022-09-16
International Journal of COPD
Abstract:Fu-zhen Yuan, 1 Wei Shui, 2 Yan-li Xing, 2 Yuan-yuan Niu, 2 Xin Zhang, 2 Chang-ran Zhang 2 1 Department of General Practice Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China; 2 Department of General Medicine, The Eastern Hospital of the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China Correspondence: Chang-ran Zhang, Department of General Medicine, The Eastern Hospital of the First Affiliated Hospital, Sun Yat-sen University, No. 183, Huangpu East Road, Huangpu District, Guangzhou, People's Republic of China, Tel +86 13711409903, Email Purpose: Previous studies have shown that the red cell index (RCI) can be considered as a simple and useful method to evaluate respiratory function. However, at present its association with adverse hospitalization outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is not fully understood. Our study aimed to examine the relationship between adverse hospitalization outcomes and RCI among AECOPD patients. Patients and Methods: We performed a retrospective analysis of consecutive patients from January 2015 to October 2021. In this study, RCI was the independent variable, measured at baseline, and adverse hospitalization outcome was the dependent variable. According to the RCI median (RCI=2.221), we divided 377 patients into two roughly equal groups (188 and 189, respectively). Next, the association between RCI and adverse hospitalization outcomes was explored using multivariable logistic regression models. To identify any non-linear relationship, a generalized additive model (GAM) was employed. Results: With a total of 377 patients with AECOPD, we divided them into two roughly equal groups to compare the clinical factors and RCI levels. The patients in the higher RCI group showed poorer outcome incidence (18 [9.57%] vs 31 [16.40%]; p = 0.049). After accounting for potential confounders, the results showed that RCI was positively associated with adverse hospitalization outcomes (odds ratio [OR] = 1.15, 95% CI: 1.01– 1.32). In addition, a non-linear relationship was detected between RCI and adverse hospitalization outcomes, which had an inflection point of 3.2. There were odds ratios and confidence intervals of 0.8 (0.7– 1.0) and 1.3 (1.2– 1.4) on the left and right sides of the inflection point, respectively. Conclusion: The RCI and adverse hospitalization outcomes exhibited a non-linear relationship in the AECOPD patients. RCI is strongly positively correlated with adverse hospitalization outcomes when it was greater than 3.2. Keywords: AECOPD, RCI, worse hospitalization outcomes, non-linearity Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable chronic lung disease that causes progressive breathing difficulties. According to the World Health Organization, in 2019, 3.23 million people died from COPD globally, accounting for 6% of all global deaths in that year, and over 90% of these deaths occurred in low- and middle-income countries, including China. 1 Over the next 40 years, the prevalence of COPD is expected to rise, with more than 5.4 million people likely to die from COPD and related conditions each year by 2060. 2–4 AECOPD is defined as ≥2 respiratory symptoms (increased frequency or severity of cough, increased sputum volume or purulent sputum, and wheezing) that cause the patient's attending physician to change the original treatment. 5 It is the most common cause of hospitalization and a significant contributor to mortality among COPD patients. 6 The diagnosis of COPD is currently based on a forced expiratory volume in 1 second (FEV 1 ) to forced vital capacity (FVC) ratio of less than 0.70 as determined by spirometry after bronchodilator use. 5 For many years, physical methods have been used to evaluate pulmonary ventilation and respiratory function, such as the vital capacity test. 7,8 However, these methods are often susceptible to patient subjective factors, and they are particularly inappropriate for children and bedridden individuals. A blood gas analysis can be used for evaluating the respiratory function of bedridden patients. When using this method, it is crucial to collect arterial blood samples under vacuum conditions and then to perform rapid analysis under vacuum. The results may be affected if the preliminary treatment is not appropriate. 9 It is known that increased levels of red blood cells (RBC) and hemoglobin (Hb) can compensate for poor pulmonary function and reflects hypoxia sensitivity. 10 These values may therefore be co -Abstract Truncated-